The Canadian next-generation sequencing market is ready for significant growth through 2032, according to a recent assessment. Driving this increasing trend are multiple factors, including a rising incidence of genetic diseases, an expanding attention on precision treatment, and ongoing improvements in sequencing platforms. Furthermore, the governm